chrX-71366341-G-C

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2

The ENST00000715246.1(TAF1):​c.27G>C​(p.Leu9Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000373 in 1,207,289 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). Synonymous variant affecting the same amino acid position (i.e. L9L) has been classified as Benign.

Frequency

Genomes: 𝑓 0.000036 ( 0 hom., 0 hem., cov: 20)
Exomes 𝑓: 0.000037 ( 0 hom. 10 hem. )

Consequence

TAF1
ENST00000715246.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.640

Publications

2 publications found
Variant links:
Genes affected
TAF1 (HGNC:11535): (TATA-box binding protein associated factor 1) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is the basal transcription factor TFIID, which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes the largest subunit of TFIID. This subunit binds to core promoter sequences encompassing the transcription start site. It also binds to activators and other transcriptional regulators, and these interactions affect the rate of transcription initiation. This subunit contains two independent protein kinase domains at the N- and C-terminals, but also possesses acetyltransferase activity and can act as a ubiquitin-activating/conjugating enzyme. Mutations in this gene result in Dystonia 3, torsion, X-linked, a dystonia-parkinsonism disorder. Alternative splicing of this gene results in multiple transcript variants. This gene is part of a complex transcription unit (TAF1/DYT3), wherein some transcript variants share exons with TAF1 as well as additional downstream DYT3 exons. [provided by RefSeq, Oct 2013]
TAF1 Gene-Disease associations (from GenCC):
  • intellectual disability, X-linked, syndromic 33
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • X-linked dystonia-parkinsonism
    Inheritance: XL, Unknown Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant X-71366341-G-C is Benign according to our data. Variant chrX-71366341-G-C is described in ClinVar as [Benign]. Clinvar id is 2197464.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.64 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 10 XL,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TAF1NM_004606.5 linkc.-34G>C upstream_gene_variant ENST00000423759.6 NP_004597.3 P21675

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TAF1ENST00000423759.6 linkc.-34G>C upstream_gene_variant 5 NM_004606.5 ENSP00000406549.2 P21675

Frequencies

GnomAD3 genomes
AF:
0.0000365
AC:
4
AN:
109616
Hom.:
0
Cov.:
20
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000760
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000600
AC:
11
AN:
183238
AF XY:
0.0000295
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000255
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000367
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000374
AC:
41
AN:
1097673
Hom.:
0
Cov.:
33
AF XY:
0.0000275
AC XY:
10
AN XY:
363279
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26373
American (AMR)
AF:
0.000312
AC:
11
AN:
35204
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19382
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30203
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54117
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40533
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3697
European-Non Finnish (NFE)
AF:
0.0000321
AC:
27
AN:
842108
Other (OTH)
AF:
0.0000434
AC:
2
AN:
46056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000365
AC:
4
AN:
109616
Hom.:
0
Cov.:
20
AF XY:
0.00
AC XY:
0
AN XY:
31816
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
29969
American (AMR)
AF:
0.00
AC:
0
AN:
10185
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2624
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3488
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2550
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5802
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
234
European-Non Finnish (NFE)
AF:
0.0000760
AC:
4
AN:
52631
Other (OTH)
AF:
0.00
AC:
0
AN:
1459
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000529
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Dec 27, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
0.28
DANN
Benign
0.51
PhyloP100
-0.64
PromoterAI
0.014
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs755801009; hg19: chrX-70586191; API